Studying Bone Thinning Risk Factors in People After Stroke
Compares bone density and bone thinning in stroke survivors and people without stroke.
Plain-language title generated from the registry record
Registry title: Assessment and Comparison of Osteoporosis Risk Factors After Stroke
Key facts
- Where
- Ankara, TürkiyeSee the site
AI summary: who the study is looking for
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults aged 55 to 85 who had a stroke, and also adults of the same age who never had a stroke, to compare bone health.
- Age
- 55 to 85 years
- Sex
- All sexes can join.
- Disease stage
- People who had an ischemic or hemorrhagic stroke between 1 week and 6 months ago, or more than 1 year ago. The stroke must have caused loss of physical function. A separate group has no history of stroke.
- Earlier treatment
- People who have had osteoporosis treatment before or after the stroke cannot join. A bone density (BMD) scan within the last year also rules out joining.
Main reasons for not taking part
- Other nerve disease besides stroke, or a psychiatric condition
- Earlier stroke that came back, or (for the non-stroke group) any earlier brain blood-vessel event
- Fragility fracture, hip fracture or hip prosthesis
- Other illness or medicine that can cause secondary osteoporosis
- Other condition that limits physical function, such as amputation or severe fracture
Read by machine on 12 November 2026.
Could this be for you?
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 55 and 85 years old?
Source: NCT07228611, who can take part
Where in Türkiye
- Ankara Etlik City HospitalAnkara, TürkiyeContact: Ayşe Naz Kalem Özgen, SpecialistTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorTrial details
- Who runs it
- Ankara Etlik City Hospital
- Trial code
- NCT07228611
- Record updated
- 2 November 2026
- Original description
The aim of this study is to evaluate the effects of stroke and associated clinical, functional, nutritional, and muscular factors, including handgrip strength, on bone mineral density and osteoporosis by comparing patients with subacute stroke, patients with chronic stroke, and non-stroke controls. By identifying factors associated with reduced bone mineral density and osteoporosis across these groups, the study is expected to contribute to the identification of high-risk patients and provide a basis for future research aimed at improving screening and treatment strategies. No significant risks are anticipated from participation in this study.Read full original descriptionShow less
Comparison of Osteoporosis Risk in the Subacute and Chronic Periods Following Stroke and Evaluation of Factors Increasing Osteoporosis
The aim of this study is to evaluate the effects of stroke and associated clinical, functional, nutritional, and muscular factors, including handgrip strength, on bone mineral density and osteoporosis by comparing patients with subacute stroke, patients with chronic stroke, and non-stroke controls. By identifying factors associated with reduced bone mineral density and osteoporosis across these groups, the study is expected to contribute to the identification of high-risk patients and provide a basis for future research aimed at improving screening and treatment strategies. No significant risks are anticipated from participation in this study.
Inclusion: Diagnosis of ischemic or hemorrhagic stroke; Between 1 week and 6 months or >1 year has passed since the date of the event; Being between 55 and 85 years of age.
Exclusion: Having received osteoporosis treatment before or after the stroke; Having received osteoporosis treatment; The patient has additional neurological conditions besides stroke; The patient has a psychiatric condition; History of recurrent stroke; BMD scan performed within the last year for stroke patients; The patient having a fragility fracture before the stroke; The patient having an additional condition that affects physical function before the stroke (amputation, severe fracture); The patient has an additional disease or medication use that could cause secondary osteoporosis; Presence of a neurological condition causing significant physical functional impairment; Presence of a psychiatric condition that may interfere with participation in the study or completion of assessments; History of any cerebrovascular event, including transient ischemic attack; History of fragility fracture; History of hip fracture or presence of a hip prosthesis; Presence of any medical or musculoskeletal condition causing significant physical functional impairment or mobility limitations (e.g., amputation or severe fracture); Presence of any disease or medication use associated with secondary osteoporosis; The patient's stroke did not cause physical function loss Inclusion Criteria for Non-Stroke Controls; No history of ischemic or hemorrhagic stroke; Being between 55 and 85 years of age; Ability to undergo the required clinical assessments and DXA measurements; The patient having a hip fracture or hip prosthesis; Having undergone a BMD scan within the last year.